EIKN
Eikon Therapeutics, Inc.
7.50$
+2.9%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|
| 0.00 | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | – | – | – | 0.09 | 0.09 | 0.09 | – | |
| – | – | – | – | -0.09 | -0.09 | -0.09 | – | |
| 1.00 | – | – | 1.10 | 1.20 | 1.29 | 1.39 | 4.99 | |
| 0.26 | – | – | 0.29 | 0.33 | 0.32 | 0.33 | 1.27 | |
| 1.26 | – | – | 1.38 | 1.44 | 1.52 | 1.63 | 5.97 | |
| -1.26 | – | – | -1.38 | -1.54 | -1.61 | -1.72 | -6.25 | |
| 0.00 | – | – | – | 0.00 | – | – | – | |
| -1.20 | – | – | -1.32 | -1.47 | -1.53 | -1.63 | -5.95 | |
| -1.20 | – | – | -1.32 | -1.47 | -1.53 | -1.63 | -5.95 | |
| – | – | – | -1.04 | -1.38 | -1.44 | -1.63 | -5.49 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.